Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3440)
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
748
Price
$33.38
Total Value
$24.96K
Shares Held After
12,207
% of Holdings
5.8%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,033
Price
$32.74
Total Value
$33.82K
Shares Held After
12,955
% of Holdings
7.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
922
Price
$33.38
Total Value
$30.77K
Shares Held After
12,554
% of Holdings
6.8%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
1,274
Price
$32.74
Total Value
$41.71K
Shares Held After
13,476
% of Holdings
8.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
2,587
Price
$33.38
Total Value
$86.34K
Shares Held After
47,484
% of Holdings
5.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
3,577
Price
$32.74
Total Value
$117.11K
Shares Held After
50,071
% of Holdings
6.7%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
24,218
Price
$33.56
Total Value
$812.84K
Shares Held After
1,146,631
% of Holdings
2.1%
CORCEPT THERAPEUTICS INC (CORT)
BAKER G LEONARD JR — Director
Shares
75,782
Price
$33.00
Total Value
$2.50M
Shares Held After
1,122,413
% of Holdings
6.8%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, R&D
Shares
18,667
Price
$94.24
Total Value
$1.76M
Shares Held After
234,800
% of Holdings
7.4%
Zai Lab Ltd (ZLAB)
GAYNOR RICHARD — Director
Shares
1,731
Price
$18.91
Total Value
$32.73K
Shares Held After
56,630
% of Holdings
3.1%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
405
Price
$56.26
Total Value
$22.79K
Shares Held After
28,975
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
1,487
Price
$55.39
Total Value
$82.36K
Shares Held After
29,380
% of Holdings
4.8%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
10,043
Price
$28.10
Total Value
$282.21K
Shares Held After
62,085
% of Holdings
13.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.40
Total Value
$255.40K
Shares Held After
499,258
% of Holdings
3.7%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
10,172
Price
$73.21
Total Value
$744.66K
Shares Held After
82,660
% of Holdings
11.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
23,928
Price
$62.15
Total Value
$1.49M
Shares Held After
430,330
% of Holdings
5.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
12,673
Price
$62.15
Total Value
$787.63K
Shares Held After
454,258
% of Holdings
2.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
4,397
Price
$62.15
Total Value
$273.27K
Shares Held After
153,902
% of Holdings
2.8%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
7,636
Price
$62.15
Total Value
$474.58K
Shares Held After
158,299
% of Holdings
4.6%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
2,916
Price
$62.15
Total Value
$181.23K
Shares Held After
71,573
% of Holdings
3.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
5,626
Price
$62.15
Total Value
$349.66K
Shares Held After
74,489
% of Holdings
7.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
4,935
Price
$62.15
Total Value
$306.71K
Shares Held After
87,127
% of Holdings
5.4%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
7,956
Price
$3.39
Total Value
$26.97K
Shares Held After
1,180,318
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
530,000
Price
$5.00
Total Value
$2.65M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$540.92
Total Value
$43.27K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$540.10
Total Value
$421.28K
Shares Held After
40,593
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,709
Price
$539.40
Total Value
$921.83K
Shares Held After
41,373
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$25.65
Total Value
$10.70K
Shares Held After
76,140
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
45
Price
$533.51
Total Value
$24.01K
Shares Held After
125
% of Holdings
26.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
708
Price
$6.74
Total Value
$4.77K
Shares Held After
9,099
% of Holdings
7.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,766
Price
$13.92
Total Value
$108.07K
Shares Held After
232,699
% of Holdings
3.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
15,534
Price
$14.00
Total Value
$217.48K
Shares Held After
240,465
% of Holdings
6.1%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,767
Price
$13.92
Total Value
$108.09K
Shares Held After
255,999
% of Holdings
2.9%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
64,768
Price
$28.21
Total Value
$1.83M
Shares Held After
62,085
% of Holdings
51.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.41
Total Value
$255.59K
Shares Held After
503,596
% of Holdings
3.6%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
41,861
Price
$28.68
Total Value
$1.20M
Shares Held After
15,804
% of Holdings
72.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
3,961
Price
$37.77
Total Value
$149.61K
Shares Held After
112,018
% of Holdings
3.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
5,950
Price
$37.11
Total Value
$220.80K
Shares Held After
115,979
% of Holdings
4.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
9,440
Price
$72.77
Total Value
$686.90K
Shares Held After
92,832
% of Holdings
9.2%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
205,608
Price
$72.38
Total Value
$14.88M
Shares Held After
102,272
% of Holdings
66.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
450,000
Price
$5.00
Total Value
$2.25M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
8,785
Price
$37.77
Total Value
$331.81K
Shares Held After
404,778
% of Holdings
2.1%
Showing 101–150 of 3440 transactions (page 3 of 69)